Lau, Wallis C Y

Psychotropic medicine consumption in 65 countries and regions, 2008-19: A longitudinal study

Brauer, R., Alfageh, B., Blais, J. E., Chan, E. W., Chui, C. S. L., Hayes, J. F., Man, K. K. C., Lau, W. C. Y., Yan, V. K. C., Beykloo, M. Y., et al. (2021) · The Lancet Psychiatry

Mental Health Treatment and AccessPharmaceutical Economics and Policy

Cited by 203

Association of risk of suicide attempts with methylphenidate treatment

Man, K. K. C., Coghill, D., Chan, E. W., Lau, W. C. Y., Hollis, C., Liddle, E., Banaschewski, T., McCarthy, S., Neubert, A., Sayal, K., et al. (2017) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderSuicide and Self-Harm Studies

Cited by 140

Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study

Man, K. K. C., Chan, E. W., Ip, P., Coghill, D., Simonoff, E., Chan, P. K. L., Lau, W. C. Y., Schuemie, M. J., Sturkenboom, M. C. J. M., & Wong, I. C. K. (2017) · BMJ

Attention Deficit Hyperactivity DisorderPregnancy and Medication Impact

Cited by 135

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study

Chan, A. Y. L., Ma, T.-T., Lau, W. C. Y., Ip, P., Coghill, D., Gao, L., Jani, Y. H., Hsia, Y., Wei, L., Taxis, K., et al. (2023) · eClinicalMedicine

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 95

Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system

Man, K. K. C., Coghill, D., Chan, E. W., Lau, W. C. Y., Hollis, C., Liddle, E., Banaschewski, T., McCarthy, S., Neubert, A., Sayal, K., et al. (2016) · Translational Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 70

Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study.

Man, K. K. C., Lau, W. C. Y., Coghill, D., Besag, F. M. C., Cross, J. H., Ip, P., & Wong, I. C. K. (2020) · The Lancet Child & Adolescent Health

Attention Deficit Hyperactivity DisorderEpilepsy research and treatment

Cited by 68

Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes

Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Pedroso Camargos, A., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., et al. (2024) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 47

Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study

Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Camargos, A. P., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., et al. (2024) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 46

Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: a systematic review and meta-analysis.

Man, K. K. C., Chan, E. W., Ip, P., Coghill, D., Simonoff, E., Chan, P. K. L., Lau, W. C. Y., Schuemie, M. J., Sturkenboom, M. C. J. M., & Wong, I. C. K. (2018) · Neuroscience & Biobehavioral Reviews

Prenatal Substance Exposure EffectsAttention Deficit Hyperactivity Disorder

Cited by 32